Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
about
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cellsHeart regenerationCardiac applications for human pluripotent stem cellsThe clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantationCoupling primary and stem cell-derived cardiomyocytes in an in vitro model of cardiac cell therapy.Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells.Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial HypertensionIsoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cellsStem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct modelEngineered early embryonic cardiac tissue increases cardiomyocyte proliferation by cyclic mechanical stretch via p38-MAP kinase phosphorylation.Electromechanical Conditioning of Adult Progenitor Cells Improves Recovery of Cardiac Function After Myocardial Infarction.Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell functionFerritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart.Aging-induced collateral dysfunction: impaired responsiveness of collaterals and susceptibility to apoptosis via dysfunctional eNOS signaling.EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice.MiRiad Roles for MicroRNAs in Cardiac Development and Regeneration.Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in ratsInfarct restraint to limit adverse ventricular remodeling.Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes.Chemokines and inflammation in heart disease: adaptive or maladaptive?Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophagesImmunological barriers to stem-cell based cardiac repairCelastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1.Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesisInduced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.Laser patterning for the study of MSC cardiogenic differentiation at the single-cell level.Transcriptome transfer provides a model for understanding the phenotype of cardiomyocytesModification of infarct material properties limits adverse ventricular remodeling.Myocardial restoration: is it the cell or the architecture or both?Cardiac regenerationCellular retrograde cardiomyoplasty and relaxin therapy for postischemic myocardial repair in a rat modelPolymer microarray technology for stem cell engineering.Systems approaches to preventing transplanted cell death in cardiac repair.Identification of Angiogenesis Rich-Viable Myocardium using RGD Dimer based SPECT after Myocardial Infarction.Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytesMyocardial repair: from salvage to tissue reconstruction.Slow turning lateral vessel bioreactor improves embryoid body formation and cardiogenic differentiation of mouse embryonic stem cells.Features of cardiomyocyte proliferation and its potential for cardiac regeneration.Carbon nanotube-based substrates promote cardiogenesis in brown adipose-derived stem cells via β1-integrin-dependent TGF-β1 signaling pathwayMonocyte transplantation for neural and cardiovascular ischemia repair
P2860
Q21134034-3EB0C6E3-AF52-4E47-8511-FD89E60BF9CFQ24562846-EFBE937E-55C5-428A-91F9-3B6772F8FD89Q24615347-BE9DB3D1-EB70-42BB-8C42-BF61FE4D4F06Q26748595-10A4B881-5DA3-4140-A4DB-A4BA262EDC1BQ27309041-BD4078CD-99AB-4CB3-9714-CBF4B9BF7C1AQ27335280-05BF3744-D656-453F-B4F0-DC4A9FCB857AQ28553086-CE8EE9FA-B41C-4A10-B90B-0DDED58D4B56Q30496731-537CDE1C-6680-4380-8FC6-4785B62AB479Q33509006-05990C99-C377-4089-9D2D-13462D78CCACQ33606453-56683909-0A72-4ECB-9150-4E08ABCF7595Q33722403-A8A6ADCB-1752-4578-BC1B-93ED62EADDBAQ33726792-6F07584C-6345-4CEF-80D5-BFA6FFF9D60BQ33847759-D5FD97BB-30B0-4BCE-84E2-795ED5A75431Q33888187-E4389BD4-0A97-4416-A37C-4F8E9BF6DD4BQ34100286-BABD31AD-1640-4FAE-91FD-2CBCD123EEF9Q34341540-57BD6FCA-9D12-425A-B229-6A06D92558C3Q34355730-D47671AE-9D63-42C3-9D79-D622B550EA63Q34491735-06E5FB69-765F-4719-8A43-236370857021Q34618217-C04E562F-A0BD-4EA1-9705-191A8CF47868Q34625604-0E32AA26-4071-4FF5-8924-13FC8B8E3983Q34639045-940CD880-36B8-4BFE-A54C-7E8FF16E183FQ34774684-F5E8F9D5-B608-4C74-BB27-139308BD94AAQ34953350-F8BC8B5B-A8A1-4A5F-A7B1-6A45996EA384Q34995850-DEB490DD-9D4D-43BB-8272-76288362F198Q35028209-7C7318CE-2364-4DCF-AB17-480578174181Q35094191-1F3AC04D-AAE9-4977-B7DB-6B91A4F90B97Q35123028-3EF19AAA-D47D-483A-B9DA-0B6783D77F6AQ35662201-B1ECA946-35EA-465D-BCB1-DCCC588AB151Q35778889-9A37C1B1-1F04-4EFF-970D-93D24C620D22Q35928368-E206B37A-23DE-4492-A545-3AAD752EC822Q36176574-6ADED5D1-734E-4DCC-B6BD-BFD5F893C861Q36739592-921065DA-6933-4F51-9E53-898915DA199DQ36984663-4CEF0892-EE64-4D4E-91AE-793DC1D8A2B6Q36990685-C245BAB9-EBBB-409B-946A-E9B605D1B76FQ37162536-20180C23-35F3-405E-8CF7-9C189CEC5C54Q37176440-D9B2C6F3-67AD-48F5-A8E4-6931029F64B4Q37208225-FF91F462-0FE2-495F-9D15-D4229F7D1646Q37228759-AB104D96-B95C-4CA9-A09C-8E1B607C526EQ37248688-C6E9AC68-9FDA-4C64-B77B-5F5C495E6F53Q37296292-3A491786-8AF3-412F-91C0-D661225E8155
P2860
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
@en
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
@nl
type
label
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
@en
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
@nl
prefLabel
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
@en
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
@nl
P2093
P1476
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms
@en
P2093
Charles E Murry
Stephan Zbinden
Stephen E Epstein
P304
P356
10.1146/ANNUREV.PATHOL.2.010506.092038
P577
2007-01-01T00:00:00Z